Related references
Note: Only part of the references are listed.In vitro activities of 'new' and 'conventional' antibiotics against multidrug resistant Gram negative bacteria from patients in the intensive care unit
I. Ratnam et al.
PATHOLOGY (2007)
In vitro activities of carbapenem/sulbactam combination, colistin, colistin/rifampicin combination and tigecycline against carbapenem-resistant Acinetobacter baumannii
Joon Young Song et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Early experience with tigecycline for ventilator-associated pneumonia and bacteremia caused by multidrug-resistant Acinetobacter baumannii
Jason J. Schafer et al.
PHARMACOTHERAPY (2007)
Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections
Jian Li et al.
LANCET INFECTIOUS DISEASES (2006)
Steady-state serum and intrapulmonary pharmacokinetics and pharmacodynamics of tigecycline
JE Conte et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2005)
Performance of the Mortality Probability Models in assessing severity of illness during the first week in the intensive care unit
M Rué et al.
CRITICAL CARE MEDICINE (2000)
Share Paper
